文献速递骨质疏松与代谢性骨病

慢性阻塞性肺疾病患者肌肉与骨量丢失伴脂肪增加及骨折:5年随访队列研究

Loss of muscle and bone mass with increased adiposity and fractures in patients with chronic obstructive pulmonary disease: A 5-year follow-up cohort study.
PubMed 文献 · Osteoporos Int · 2025-11-22

该观察性队列研究对40例慢性阻塞性肺疾病(COPD)患者基线及中位随访58个月后复评,发现椎体骨折率从22.5%升至38.5%、非椎体骨折率从12.5%升至17.5%,同时四肢瘦体重和全髋骨密度下降、脂肪质量指数升高,半数骨折发生在骨密度T值>-2.5的患者中。

要点

  • COPD患者5年随访期间椎体骨折率由22.5%升至38.5%(P=0.031),非椎体骨折率由12.5%升至17.5%(P<0.001)。
  • 四肢瘦体重由17.5±4.0降至16.5±4.1 kg/m2,全髋骨密度由0.901±0.144降至0.862±0.136 g/cm2,脂肪质量指数由8.5±5.4升至11.8±5.8 g/cm2(均P<0.001)。
  • 半数骨折发生于骨密度T值>-2.5的患者;血清25-羟维生素D<30 ng/mL和基线腰椎骨密度分别为脂肪丢失(OR=8.33,95%CI 1.16-59.93;P=0.035)和脊柱骨丢失(OR=1.05,95%CI 1.01-1.10;P=0.037)的显著预测因素。

核心结论

  • COPD患者5年随访期间出现骨密度与瘦体重显著丢失,伴脂肪增加和骨折发生。

研究设计与样本

  • 观察性队列研究,纳入来自三级医院的40例COPD患者(平均年龄69.0±7.5岁;女性21例),基线入组时间为2013年11月至2015年12月,中位随访58个月后复评。

主要发现

  • 椎体骨折率从22.5%升至38.5%(P=0.031),非椎体骨折率从12.5%升至17.5%(P<0.001)。
  • 半数骨折发生于骨密度T值>-2.5的患者。
  • 四肢瘦体重从17.5±4.0降至16.5±4.1 kg/m2(P<0.001),全髋骨密度从0.901±0.144降至0.862±0.136 g/cm2(P<0.001),脂肪质量指数从8.5±5.4升至11.8±5.8 g/cm2(P<0.001)。
  • 血清25-羟维生素D<30 ng/mL是脂肪丢失的显著预测因素(OR=8.33,95%CI 1.16-59.93;P=0.035),基线腰椎骨密度是脊柱骨丢失的显著预测因素(OR=1.05,95%CI 1.01-1.10;P=0.037)。
  • 较高气流阻塞是骨丢失与 incident fracture 复合结局的显著预测因素(OR=22.04,95%CI 1.17-416.52;P=0.039)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Musculoskeletal fragility in Chronic obstructive pulmonary disease (COPD) is often overlooked. Using an observational cohort of COPD patients followed over five years, a higher fracture rate was observed alongside significant loss of bone and muscle mass, as well as increased fat mass index. PURPOSE: Chronic obstructive pulmonary disease (COPD) is associated with a higher risk of sarcopenia and fractures. We aim to assess changes in body composition and bone mineral density (BMD), and the occurrence of fractures in patients with COPD from a tertiary hospital. METHODS: Forty patients with COPD (mean age 69.0 ± 7.5 years; 21 women) who joined the cohort at baseline (November 2013 to December 2015) were reevaluated after a median follow-up of 58 months (final assessment). BMD, appendicular lean mass (ALM), body fat (BF), and fat mass index (FMI) were measured using DXA, along with spine radiography with vertebral morphometry at both assessments. RESULTS: There was a significant increase in the rates of vertebral (22.5% versus 38.5%; P = 0.031) and non-vertebral (12.5% versus 17.5%; P < 0.001) fractures. Half of the fractures occurred in patients with a BMD T-score > -2.5. Notable decreases were observed in ALM (17.5 ± 4.0 versus 16.5 ± 4.1 kg/m2; P < 0.001) and total femur BMD (0.901 ± 0.144 versus 0.862 ± 0.136 g/cm2; P < 0.001), along with an increase in FMI (8.5 ± 5.4 versus 11.8 ± 5.8 g/cm2; P < 0.001). Serum 25-hydroxyvitamin D < 30 ng/mL and baseline lumbar spine BMD were significant predictors of fat mass loss (OR = 8.33, 95% CI 1.16-59.93; P = 0.035) and bone loss at the spine (OR = 1.05, 95% CI 1.01-1.10; P = 0.037), respectively. Higher airflow obstruction was a significant predictor for the combined outcome of bone loss and incident fracture (OR = 22.04, 95% CI 1.17-416.52; P = 0.039). CONCLUSION: Over a 5-year follow-up, COPD patients experience a significant loss of BMD and lean mass, along with increased adiposity and fractures.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Graumam RQ, Silva LVA, Pinheiro MMC, et al. Loss of muscle and bone mass with increased adiposity and fractures in patients with chronic obstructive pulmonary disease: A 5-year follow-up cohort study. Osteoporos Int. 2025. PMID: 41273373. doi:10.1007/s00198-025-07776-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。